BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27903510)

  • 1. Vitamin D supplementation reduces some AT1-AA-induced downstream targets implicated in preeclampsia including hypertension.
    Faulkner JL; Amaral LM; Cornelius DC; Cunningham MW; Ibrahim T; Heep A; Campbell N; Usry N; Wallace K; Herse F; Dechend R; LaMarca B
    Am J Physiol Regul Integr Comp Physiol; 2017 Jan; 312(1):R125-R131. PubMed ID: 27903510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D supplementation improves pathophysiology in a rat model of preeclampsia.
    Faulkner JL; Cornelius DC; Amaral LM; Harmon AC; Cunningham MW; Darby MM; Ibrahim T; Thomas DS; Herse F; Wallukat G; Dechend R; LaMarca B
    Am J Physiol Regul Integr Comp Physiol; 2016 Feb; 310(4):R346-54. PubMed ID: 26676250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of endogenous angiotensin II type I receptor agonistic autoantibody activity improves mitochondrial reactive oxygen species and hypertension in a rat model of preeclampsia.
    Vaka VR; Cunningham MW; Deer E; Franks M; Ibrahim T; Amaral LM; Usry N; Cornelius DC; Dechend R; Wallukat G; LaMarca BD
    Am J Physiol Regul Integr Comp Physiol; 2020 Feb; 318(2):R256-R262. PubMed ID: 31721604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy.
    Brewer J; Liu R; Lu Y; Scott J; Wallace K; Wallukat G; Moseley J; Herse F; Dechend R; Martin JN; Lamarca B
    Hypertension; 2013 Nov; 62(5):886-92. PubMed ID: 24041954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia.
    LaMarca B; Parrish MR; Wallace K
    Gend Med; 2012 Jun; 9(3):139-46. PubMed ID: 22498426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats.
    Cunningham MW; Castillo J; Ibrahim T; Cornelius DC; Campbell N; Amaral L; Vaka VR; Usry N; Williams JM; LaMarca B
    Hypertension; 2018 May; 71(5):886-893. PubMed ID: 29555668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats.
    Novotny SR; Wallace K; Heath J; Moseley J; Dhillon P; Weimer A; Wallukat G; Herse F; Wenzel K; Martin JN; Dechend R; Lamarca B
    Am J Physiol Regul Integr Comp Physiol; 2012 May; 302(10):R1197-201. PubMed ID: 22461177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal natural killer cell activation and mitochondrial oxidative stress; new mechanisms in AT1-AA mediated hypertensive pregnancy.
    Cunningham MW; Vaka VR; McMaster K; Ibrahim T; Cornelius DC; Amaral L; Campbell N; Wallukat G; McDuffy S; Usry N; Dechend R; LaMarca B
    Pregnancy Hypertens; 2019 Jan; 15():72-77. PubMed ID: 30825931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.
    LaMarca B; Parrish M; Ray LF; Murphy SR; Roberts L; Glover P; Wallukat G; Wenzel K; Cockrell K; Martin JN; Ryan MJ; Dechend R
    Hypertension; 2009 Oct; 54(4):905-9. PubMed ID: 19704104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B2 cells contribute to hypertension and natural killer cell activation possibly via AT1-AA in response to placental ischemia.
    Herrock OT; Deer E; Amaral LM; Campbell N; Lemon J; Ingram N; Cornelius DC; Turner TW; Fitzgerald S; Ibrahim T; Dechend R; Wallukat G; LaMarca B
    Am J Physiol Renal Physiol; 2023 Feb; 324(2):F179-F192. PubMed ID: 36417275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of T cell stimulated agonistic autoantibodies to the angiotensin II type I receptor (AT1-AA) in mediating multiorgan dysfunction in IL-17 induced hypertension during pregnancy.
    Hogg JP; Campbell N; Deer E; Fitzgerald S; Cornelius D; Hoang N; Turner T; Amaral L; Lemon JP; Ibrahim T; LaMarca B
    Am J Reprod Immunol; 2024 Apr; 91(4):e13843. PubMed ID: 38606700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II-Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy.
    Cunningham MW; Williams JM; Amaral L; Usry N; Wallukat G; Dechend R; LaMarca B
    Hypertension; 2016 Nov; 68(5):1308-1313. PubMed ID: 27698062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endothelin 1 and angiotensin II in preeeclampsia].
    Ariza AC; Bobadilla NA; Halhali A
    Rev Invest Clin; 2007; 59(1):48-56. PubMed ID: 17569300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension.
    Parrish MR; Wallace K; Tam Tam KB; Herse F; Weimer A; Wenzel K; Wallukat G; Ray LF; Arany M; Cockrell K; Martin JN; Dechend R; LaMarca B
    Am J Hypertens; 2011 Jul; 24(7):835-40. PubMed ID: 21472019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 1 receptor autoantibody blockade improves cerebral blood flow autoregulation and hypertension in a preclinical model of preeclampsia.
    Duncan JW; Azubuike D; Booz GW; Fisher B; Williams JM; Fan F; Ibrahim T; LaMarca B; Cunningham MW
    Hypertens Pregnancy; 2020 Nov; 39(4):451-460. PubMed ID: 33119997
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin II type 1 receptor agonistic autoantibody blockade improves postpartum hypertension and cardiac mitochondrial function in rat model of preeclampsia.
    Booz GW; Kennedy D; Bowling M; Robinson T; Azubuike D; Fisher B; Brooks K; Chinthakuntla P; Hoang NH; Hosler JP; Cunningham MW
    Biol Sex Differ; 2021 Nov; 12(1):58. PubMed ID: 34727994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting B cell activating factor attenuates preeclamptic symptoms in placental ischemic rats.
    Herrock O; Deer E; Amaral LM; Campbell N; Whitney D; Ingram N; Cornelius DC; Turner T; Hardy-Hardin J; Booz GW; Ibrahim T; LaMarca B
    Am J Reprod Immunol; 2023 Apr; 89(4):e13693. PubMed ID: 36794639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-4 supplementation improves the pathophysiology of hypertension in response to placental ischemia in RUPP rats.
    Cottrell JN; Amaral LM; Harmon A; Cornelius DC; Cunningham MW; Vaka VR; Ibrahim T; Herse F; Wallukat G; Dechend R; LaMarca B
    Am J Physiol Regul Integr Comp Physiol; 2019 Feb; 316(2):R165-R171. PubMed ID: 30624978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced uterine perfusion pressure T-helper 17 cells cause pathophysiology associated with preeclampsia during pregnancy.
    Cornelius DC; Amaral LM; Wallace K; Campbell N; Thomas AJ; Scott J; Herse F; Wallukat G; Dechend R; LaMarca B
    Am J Physiol Regul Integr Comp Physiol; 2016 Dec; 311(6):R1192-R1199. PubMed ID: 27784685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental CD4
    Reeve KE; Deer E; Amaral LM; Cornelius DC; Herrock O; Harmon AC; Campbell N; Fitzgerald S; Ibrahim T; Wallukat G; Dechend R; LaMarca B
    Explor Med; 2022; 3(1):99-111. PubMed ID: 37645383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.